On the other hand, the present study was specifically designed to evaluate over a 12-month period the effects of GH on arterial stiffness and their sustainability in association to changes of FGF23/Klotho axis, and provided important insights on the interactions of GH/IGF1/Klotho system and CV health in CKD. This evidence concerns the gene GH1 and chronic kidney disease.